Cite
HARVARD Citation
Kantarjian, H. et al. (2018). Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study. Lancet oncology. 19 (2), pp. 240-248. [Online].